share_log

4D Pharma Temporarily Halts Patient Enrollment In Clinical Trials For Cancer, Asthma, Parkinson's Disease Drugs

4D Pharma Temporarily Halts Patient Enrollment In Clinical Trials For Cancer, Asthma, Parkinson's Disease Drugs

4D Pharma暂停患者参加癌症、哮喘和帕金森病药物的临床试验
MT Newswires ·  2022/07/04 00:14

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发